Relationship between activation of epidermal growth factor receptor and cell dissociation in pancreatic cancer

被引:1
|
作者
Tan, XD [1 ]
Egami, H [1 ]
Ishikawa, S [1 ]
Nakagawa, M [1 ]
Ishiko, T [1 ]
Kamohara, H [1 ]
Hirota, M [1 ]
Ogawa, M [1 ]
机构
[1] Kumamoto Univ, Sch Med, Dept Surg 2, Kumamoto 8608556, Japan
关键词
epidermal growth factor receptor; dissociation factor; cell dissociation; pancreatic cancer;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In our previous investigations, mitogen-activated protein kinase kinase 2 (MEK2)/extracellular signal-regulated kinase 2 (ERK2) signaling pathway was found to be correlated with the cell dissociation induced by dissociation factor (DF) in pancreatic cancer cells. In this study, the expressions of epidermal growth factor receptor (EGFR), phosphorylated EGFR (p-EGFR), and its downstream kinases MEK1/2 and ERK1/2, were analyzed to clarify the regulatory mechanism of cell dissociation in pancreatic cancer cells. Two hamster (PC-1.0 and PC-1) and two human (AsPC-1 and Capan-2) pancreatic cancer cell lines, were used. Immunocytochemical study was performed using anti-EGFR, p-EGFR, phosphorylated MEK1/2 (p-MEK1/2), and phosphorylated ERK1/2 (p-ERK1/2) antibodies. DF-treatment markedly induced the expressions of EGFR, p-EGFR, p-MEK1/2, p-ERK1/2, as well as the dissociation of cell colonies in PC-I and Capan-2 cells. In contrast, AG1478 (an EGFR inhibitor) treatment significantly induced the cell aggregation in PC-1.0 and AsPC-1 cells which usually grew as single cells, but strongly suppressed the expressions of EGFR, p-EGFR, p-MEK1/2, and p-ERK1/2. These observations demonstrate that activation of EGFR is closely involved in cell dissociation in pancreatic cancer through activating MEK/ERK signaling pathway.
引用
收藏
页码:1303 / 1309
页数:7
相关论文
共 50 条
  • [1] Induction of pancreatic cancer cell migration by an autocrine epidermal growth factor receptor activation
    Stock, Anna-Maria
    Hahn, Stephan A.
    Troost, Gabriele
    Niggemann, Bernd
    Zaenker, Kurt S.
    Entschladen, Frank
    EXPERIMENTAL CELL RESEARCH, 2014, 326 (02) : 307 - 314
  • [2] Activation of epidermal growth factor receptor by epidermal growth factor
    Sherrill, JM
    Kyte, J
    BIOCHEMISTRY, 1996, 35 (18) : 5705 - 5718
  • [3] Epidermal growth factor receptor overexpression in resected pancreatic cancer
    Mahipal, A.
    McDonald, M. J.
    Witkiewicz, A.
    Carr, B. I.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [4] Photonic modulation of epidermal growth factor receptor halts receptor activation and cancer cell migration
    Botelho, Claudia M.
    Goncalves, Odete
    Marques, Rogerio
    Thiagarajan, Viruthachalam
    Vorum, Henrik
    Gomes, Andreia C.
    Neves-Petersen, Maria Teresa
    JOURNAL OF BIOPHOTONICS, 2018, 11 (09)
  • [5] Transforming growth factor alpha and epidermal growth factor levels in bladder cancer and their relationship to epidermal growth factor receptor
    Mellon, JK
    Cook, S
    Chambers, P
    Neal, DE
    BRITISH JOURNAL OF CANCER, 1996, 73 (05) : 654 - 658
  • [6] Relationship between proliferative cell activity and epidermal growth factor receptor in gastric carcinomas
    Kovac, D
    Rubinic, M
    Stimac, D
    Uravic, M
    Ivanis, N
    Krasevic, M
    Melato, M
    Jonjic, N
    PROGRESS IN GASTRIC CANCER RESEARCH 1997: PROCEEDINGS OF THE 2ND INTERNATIONAL GASTRIC CANCER CONGRESS, 1997, : 573 - 576
  • [8] Inverse Relationship Between Estrogen Receptor and Epidermal Growth Factor Receptor mRNA Levels in Human Breast Cancer Cell Lines
    Lee, Christine S. L.
    Hall, Rosemary E.
    Alexander, Ian E.
    Koga, Masafumi
    Shine, John
    Sutherland, Robert L.
    GROWTH FACTORS, 1990, 3 (02) : 97 - 103
  • [9] THE EPIDERMAL GROWTH-FACTOR RECEPTOR IN HUMAN PANCREATIC-CANCER
    LEMOINE, NR
    HUGHES, CM
    BARTON, CM
    POULSOM, R
    JEFFERY, RE
    KLOPPEL, G
    HALL, PA
    GULLICK, WJ
    JOURNAL OF PATHOLOGY, 1992, 166 (01): : 7 - 12
  • [10] Epidermal growth factor receptor-targeted therapy for pancreatic cancer
    Xiong, HQ
    Abbruzzese, JL
    SEMINARS IN ONCOLOGY, 2002, 29 (05) : 31 - 37